• LAST PRICE
    3.9900
  • TODAY'S CHANGE (%)
    Trending Down-0.0200 (-0.4988%)
  • Bid / Lots
    3.9900/ 4
  • Ask / Lots
    4.1600/ 5
  • Open / Previous Close
    4.0300 / 4.0100
  • Day Range
    Low 3.8711
    High 4.1600
  • 52 Week Range
    Low 3.1650
    High 8.6000
  • Volume
    29,048
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 4.01
TimeVolumePULM
09:32 ET2004.03
09:37 ET2003.8711
10:18 ET4993.91
10:33 ET1004.06
10:40 ET4204.0566
10:54 ET1004.06
10:58 ET7504.0608
11:02 ET8123.88
11:36 ET8003.9423
11:38 ET2003.9862
11:48 ET5504
11:52 ET2004.02
11:54 ET3004.02
12:01 ET2474.0563
12:17 ET4004.06
12:21 ET16674.07
12:24 ET1304.0557
12:26 ET5004.07
12:48 ET10074.07
12:51 ET2004.06
12:55 ET5004.0899
01:06 ET1004.07
01:18 ET30044.1499
01:20 ET2004.14
01:24 ET15004.1201
01:26 ET2484.12
01:27 ET5004.1342
01:40 ET1004.14
01:42 ET1004.14
01:49 ET1004.14
01:51 ET2004.13
01:54 ET11004.14
01:58 ET30004.1201
02:00 ET6004.15
02:14 ET1004.14
02:32 ET2934.1327
02:39 ET2004.16
02:43 ET1004.16
02:56 ET4004.135
03:03 ET16004.1207
03:10 ET2324.085
03:32 ET9004.095
03:35 ET3004.07
03:39 ET2004.06
03:51 ET1004.015
03:55 ET8004.0699
04:00 ET8813.99
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesPULM
Pulmatrix Inc
14.6M
-0.6x
---
United StatesATHX
Athersys Inc
17.1M
-0.2x
---
United StatesAEZS
Aeterna Zentaris Inc
18.1M
-1.7x
---
United StatesERYP
Erytech Pharma SA
17.4M
0.0x
---
United StatesAGRX
Agile Therapeutics Inc
12.1M
0.0x
---
United StatesBLCM
Bellicum Pharmaceuticals Inc
11.2M
-2.6x
---
As of 2023-01-26

Company Information

Pulmatrix, Inc. is a clinical-stage biotechnology company, which is focused on the discovery and development of inhaled therapeutic products to prevent and treat respiratory and other diseases with unmet medical needs. It designs and develops inhaled therapeutic products based on its dry powder delivery technology, inhaled small particles easily respirable and emitted (iSPERSE), which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. iSPERSE powders are engineered to be small, dense particles with dispersibility and delivery to airways. iSPERSE’s lead development program, Pulmazole is its inhaled formulation of itraconazole, an anti-fungal drug commercially available as an oral drug, which it is developing to treat and prevent pulmonary fungal infections. PUR1800 is developing for the treatment of acute exacerbations of chronic obstructive pulmonary disease and PUR3100 is developing for the treatment of acute migraine.

Contact Information

Headquarters
99 Hayden Ave Ste 390LEXINGTON, MA, United States 02421-7966
Phone
781-357-2333
Fax
302-636-5454

Executives

Independent Chairman of the Board
Michael Higgins
President, Chief Executive Officer, Director
Teofilo Raad
Interim Chief Financial Officer
Peter Ludlum
Vice President - Finance
Michelle Siegert
Chief Medical Officer
Margaret Wasilewski

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$14.6M
Revenue (TTM)
$4.8M
Shares Outstanding
3.6M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.92
EPS
$-6.84
Book Value
$14.73
P/E Ratio
-0.6x
Price/Sales (TTM)
3.0
Price/Cash Flow (TTM)
---
Operating Margin
-387.32%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.